Thrombosis
News
FDA approves Abbott’s Amplatzer Amulet for AFib
Long available in Europe, the approval heats up the U.S. market of minimally invasive solutions for stroke prevention with left atrial appendage...
From the Journals
‘Striking’ difference in adverse events in women with Watchman LAAO
National registry data show higher rates of major complications and death among women with atrial fibrillation with the preventive procedure.
News
Heparin’s COVID-19 benefit greatest in moderately ill patients
A multiplatform trial reported that therapeutic heparin improved outcomes in moderately ill COVID-19 patients but not in critically ill patients...
News
FDA panel balks at TriGuard 3 cerebral embolic device for TAVR
The device offers advantages over the approved Sentinel device but could not tamp down stroke rates, the very complication it was designed to...
Conference Coverage
DOACs best aspirin after ventricular ablation: STROKE-VT
Cerebrovascular protection was far better on DOACs after catheter ablation for VT or extrasystoles in the trial and may yet be further improved....
From the Journals
Direct oral anticoagulants: Competition brought no cost relief
Medicare Part D spending since 2011 has far outpaced growth in the use of oral anticoagulants.
From the Journals
Five risk factors may predict thrombus on LAA occlusion implants
With a new clinical risk score, patients deemed at high risk showed a twofold increased rate of this worrisome complication.
From the Journals
DOACs linked to lower mortality than vitamin K antagonist: 3-year TAVR registry
Mortality and bleeding advantage favors DOACs over VKA in TAVR patients who are candidates for anticoagulation.
Feature
Early heparin treatment linked to lower COVID-19 mortality
Latest News
FDA okays 1-month dual antiplatelet therapy for Abbott’s Xience stents
The new labeling, similarly granted in Europe for as little as 28 days, gives the Xience stents the shortest DAPT indication in the world, Abbott...
From the Journals
Prophylactic anticoagulation tied to lower death rate in COVID
Prophylactic use of low-dose anticoagulation to prevent venous thromboembolism was associated with reduced 60-day mortality in patients...